Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.001 per share AZYO The Nasdaq Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran ...

Aziyo Biologics, Inc. (AZYO) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Leigh Salvo - IR Kevin Rakin - Executive Chairman Randy Mills - CEO Matthew Ferguson - CFO Conference Call Participants Josh Jennings - Cowen David Rescott - Truist Ross Osborn - Cantor Fitzgerald Operator Good day. And thank you for standing by. Welcome to the Aziyo Biologics Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's pr ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.001 per share AZYO The Nasdaq Global Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For transition period from to Commission File Number: 001-39577 Aziyo Biologics, Inc. (Exact name of registrant as specified in its charter) Delaware 47-4790334 (State or other ...

Aziyo Biologics, Inc. (AZYO) Q4 2021 Earnings Conference Call March 3, 2022 4:30 PM ET Company Participants Ronald Lloyd – President and Chief Executive Officer Matthew Ferguson – Chief Financial Officer Leigh Salvo – Investor Relations, Gilmartin Group, LLC Conference Call Participants Matthew O’Brien – Piper Sandler Companies David Rescott – Truist Securities Operator Hello, and thank you for standing by. Welcome to Aziyo Biologics, Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, ...

Aziyo Biologics, Inc. (AZYO) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Leigh Salvo - IR, Gilmartin Group LLC Ronald Lloyd - President and CEO Matthew Ferguson - CFO Conference Call Participants David Rescott - Truist Securities Operator Good day, and thank you for standing by. Welcome to the Aziyo Biologics Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-an ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39577 Aziyo Biologics, Inc. (Exact name of registrant as specified in its charter) Delaware 47-4790334 (S ...

Start Time: 16:30 January 1, 0000 5:10 PM ET Aziyo Biologics, Inc. (AZYO) Q2 2021 Earnings Conference Call August 09, 2021, 16:30 PM ET Company Participants Ronald Lloyd - President and CEO Matthew Ferguson - CFO Leigh Salvo - IR, Gilmartin Group LLC Conference Call Participants Matthew O’Brien - Piper Sandler Joshua Jennings - Cowen and Company David Rescott - Truist Securities Brandon Folkes - Cantor Fitzgerald Operator Ladies and gentlemen, thank you for standing by. Welcome to Aziyo Biologics Q2 2021 E ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.001 per share AZYO The Nasdaq Global Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the trans ...

Aziyo Biologics, Inc. (AZYO) Q1 2021 Results Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Leigh Salvo - Investor Relations, Gilmartin Group LLC Ronald Lloyd - President and Chief Executive Officer Matthew Ferguson - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Neil Chatterji - Cowen and Company David Rescott - Truist Securities Operator Welcome to the Aziyo Biologics Q1 2021 Earnings Call. My name is Ajen and I'll be your operator for today's c ...